Atlas Trials

Strain vs. Left Ventricular Ejection Fraction-based Cardiotoxicity Prevention in Breast Cancer

Clinical trial NCT04429633 · UNKNOWN

Trial details

NCT number
NCT04429633
Sponsor
Samsung Medical Center
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
CardiotoxicityBreast CancerPreventionAdjuvantTrastuzumab
Start date
2019-07-19
Primary completion
2022-07-18
Enrollment
136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.